ANAL HSIL

Clinical trials for ANAL HSIL explained in plain language.

Never miss a new study

Get alerted when new ANAL HSIL trials appear

Sign up with your email to follow new studies for ANAL HSIL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could a probiotic fight anal cancer in HIV patients?

Disease control Not yet recruiting

This study tests whether a probiotic called EXE-346 can help treat anal high-grade squamous intraepithelial lesions (HSIL) and reduce persistent high-risk HPV infection in people living with HIV. The trial will enroll 90 participants who will take the probiotic or a placebo daily…

Matched conditions: ANAL HSIL

Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control

Last updated Jul 17, 2026 00:00 UTC

ANAL HSIL

Get alerted when new ANAL HSIL trials appear

Could a probiotic fight anal cancer in HIV patients?